Transfusion-related acute lung injury: Incidence and risk factors

Blood

Volumn 119, Issue 7, 2012, Pages 1757-1767

  Toy, Pearl ^a   Gajic, Ognjen ^b   Bacchetti, Peter ^a   Looney, Mark R ^a   Gropper, Michael A ^a   Hubmayr, Rolf ^b   Lowell, Clifford A ^a   Norris, Philip J ^a,c   Murphy, Edward L ^a,c   Weiskopf, Richard B ^a   Wilson, Gregory ^b   Koenigsberg, Monique ^a   Lee, Deanna ^a   Schuller, Randy ^d   Wu, Ping ^a   Grimes, Barbara ^a   Gandhi, Manish J ^b   Winters, Jeffrey L ^b   Mair, David ^d   Hirschler, Nora ^a,e   Rosen, Rosa Sanchez ^a,c   Matthay, Michael A ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d AMERICAN RED CROSS   (United States)

^e Blood Centers of the Pacific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; INTERLEUKIN 8;

ADULT; AGED; AIRWAY PRESSURE; ALCOHOL ABUSE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE TRANSFUSION; FEMALE; FLUID BALANCE; GRANULOCYTE; HUMAN; IMMUNOFLUORESCENCE TEST; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; TRANSFUSION RELATED ACUTE LUNG INJURY; UNIVERSITY HOSPITAL; VENTILATOR;

EID: 84863116540     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-08-370932     Document Type: Article

References (50)

1. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2009. Annual Summaries 2010. http://www.fda.gov/ BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/Transfusion- DonationFatalities/ucm204763.htm. Accessed February 2, 2011.
2. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3):818-824. (Pubitemid 24082248)
3. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44(12):1774- 1789.
4. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: definiion and review. Crit Care Med. 2005;33(4):721- 726.
5. Fowler AA, Hamman RF, Good JT, et al. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med. 1983;98(5):593-597. (Pubitemid 13091168)
6. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25(6):573-577. (Pubitemid 16174471)
7. Gajic O, Rana R, Winters JL, et al. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med. 2007;176(9):886-891. (Pubitemid 350097078)
8. Vlaar AP, Hofstra JJ, Determann RM, et al. The incidence, risk factors, and outcome of transfusion- related acute lung injury in a cohort of cardiac surgery patients: a prospective nested casecontrol study. Blood. 2011;117(16):4218-4225.
9. Ness PM. Does transfusion of stored red blood cells cause clinically important adverse effects? A critical question in search of an answer and a plan. Transfusion. 2011;51(4):666-667.
10. Finlay HE, Cassorla L, Feiner J, Toy P. Designing and testing a computer-based screening system for transfusion-related acute lung injury. Am J Clin Pathol. 2005;124(4):601-609. (Pubitemid 41395642)
11. Transfusion-Related Acute Lung Injury. AABB Association Bulletin 2006. http://www.aabb.org/Content/Members-Area/Association-Bulletins/ab06-07.htm. Accessed February 2, 2011.
12. Clarifications to recommendations to reduce the risk of TRALI. AABB Association Bulletin 2007. http://www.aabb.org/Content/Members-Area/Association- Bulletins/ab07-03.htm. Accessed February 2, 2011.
13. Weiskopf RB, Feiner J, Toy P, et al. Fresh and stored red blood cell transfusion equivalently induce subclinical pulmonary gas exchange deficit in normal humans [published online ahead of print January 19, 2012]. Anesth Analg. doi: 10.1213/ANE.06013e318241fcd5.
14. Endres RO, Kleinman SH, Carrick DM, et al. Identification of specificities of antibodies against human leukocyte antigens in blood donors. Transfusion. 2010;50(8):1749-1760.
15. Carrick DM, Norris PJ, Endres RO, et al. Establishing assay cutoffs for HLA antibody screening of apheresis donors. Transfusion. 2011;51:2092-2101.
16. The SURVEYLOGISTIC Procedure. SAS/STAT(R) 9.2 User's Guide (2nd ed). 2010. http://support.sas.com/documentation/cdl/en/statug/63033/HTML/default/ viewer.htm#surveylogistic-toc.htm. Accessed February 2, 2011.
17. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999;8(1):3-15. (Pubitemid 29222784)
18. Li G, Malinchoc M, Cartin-Ceba R, et al. Eightyear trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med. 2011;183(1):59-66.
19. Eder A, Herron R, Strupp A, et al. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion. 2007;47(4):599-607. (Pubitemid 46449614)
20. SHOT Annual Reorts and Summaries (All). SHOT 2010. http://www.shotuk.org/ wp-content/uploads/2011/07/SHOT-2010-Report1.pdf. Accessed August 6, 2011.
21. Eder AF, Herron RM Jr, Strupp A, et al. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion. 2010;50(8):1732-1742.
22. Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA class II antibodies in transfusion-related acute lung injury. Transfusion. 2001;41(10):1244-1248. (Pubitemid 33000960)
23. Reil A, Keller-Stanislawski B, Gunay S, Bux J. Specificities of leucocyte alloantibodies in transfusion- related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang. 2008;95(4):313-317.
24. Chapman CE, Stainsby D, Jones H, et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion. 2009;49(3):440-452.
25. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion. 2009;49(9):1825-1835.
26. Issa N, Cosio FG, Gloor JM, et al. Transplant glomerulopathy: risk and prognosis related to antihuman leukocyte antigen class II antibody levels. Transplantation. 2008;86(5):681-685.
27. Bierling P, Bux J, Curtis B, et al. Recommendations of the ISBTWorking Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang. 2009;96(3):266-269.
28. Dykes A, Smallwood D, Kotsimbos T, Street A. Transfusion-related acute lung injury (Trali) in a patient with a single lung transplant. Br J Haematol. 2000;109(3):674-676. (Pubitemid 30415205)
29. Cooling L. Transfusion-related acute lung injury. JAMA. 2002;288(3):315-316.
30. Toy P, Hollis-Perry KM, Jun J, Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion. 2004;44(12): 1683-1688. (Pubitemid 39644050)
31. Silliman CC, Bjornsen AJ, Wyman TH, et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion. 2003;43(5):633-640. (Pubitemid 36506360)
32. Kelher MR, Masuno T, Moore EE, et al. Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood. 2009;113(9):2079-2087.
33. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101(2):454-462. (Pubitemid 36077563)
34. Silliman CC, Paterson AJ, Dickey WO, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion. 1997;37(7):719-726. (Pubitemid 27297612)
35. Muniz M, Sheldon S, Schuller RM, et al. Patient-specific transfusion-related acute lung injury. Vox Sang. 2008;94(1):70-73. (Pubitemid 350275501)
36. Bux J, Sachs UJ. The pathogenesis of transfusion- related acute lung injury (TRALI). Br J Haematol. 2007;136(6):788-799. (Pubitemid 46348408)
37. Blennerhassett JB. Shock lung and diffuse alveolar damage pathological and pathogenetic considerations. Pathology. 1985;17(2):239-247. (Pubitemid 16251023)
38. Moss M, Guidot DM, Wong-Lambertina M, Ten Hoor T, Perez RL, Brown LA. The effects of chronic alcohol abuse on pulmonary glutathione homeostasis. Am J Respir Crit Care Med. 2000;161(2):414-419. (Pubitemid 30129446)
39. Boe DM, Richens TR, Horstmann SA, et al. Acute and chronic alcohol exposure impair the phagocytosis of apoptotic cells and enhance the pulmonary inflammatory response. Alcohol Clin Exp Res. 2010;34(10):1723-1732.
40. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24): 2564-2575. (Pubitemid 43882352)
41. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome: the Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342(18):1301- 1308.
42. Iribarren C, Jacobs DR Jr, Sidney S, Gross MD, Eisner MD. Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in amanaged care setting. Chest. 2000;117(1):163-168. (Pubitemid 30053636)
43. Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005;33(1):1-6; discussion 230-232.
44. Looney MR, Nguyen JX, Hu Y, Van Ziffle JA, Lowell CA, Matthay MA. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest. 2009;119(11):3450-3461.
45. Sachs UJ, Wasel W, Bayat B, et al. Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies. Blood. 2011;117(2):669-677.
46. Gosselin EJ, Wardwell K, Rigby WF, Guyre PM. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. J Immunol. 1993;151(3):1482- 1490. (Pubitemid 23219286)
47. Geppert TD, Lipsky PE. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen- presenting cells despite comparable Ia expression. J Immunol. 1985;135(6):3750-3762. (Pubitemid 16250344)
48. Kopko PM, Paglieroni TG, Popovsky MA, Muto KN, MacKenzie MR, Holland PV. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion. 2003;43(2):177-184. (Pubitemid 36207297)
49. Yost CS, Matthay MA, Gropper MA. Etiology of acute pulmonary edema during liver transplantation: a series of cases with analysis of the edema fluid. Chest. 2001;119(1):219-223. (Pubitemid 32150570)
50. Benson AB, Burton JR Jr, Austin GL, et al. Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transpl. 2011;17(2):149-158.